Were global leaders in NAD+ research With 70,000+ NAD+ users supported and multiple peer-reviewed clinical trials, our in-house Stanford PhD-led Research Team is setting the benchmark for research-driven, clinician-guided NAD+ protocols
Antonio Brunetti Jelena Jakab, 1, 2 Blaenka Miki, 2, 3 tefica Miki, 2 Brankica Jurani, 2, 4 Vesna osi, 2 Dragan Schwarz, 2, 5 Aleksandar Vev 2 1 Faculty of Medicine, Josip Juraj Strossmayer University of Osijek, Osijek, Croatia
Specific pricing is not restated in this article because the source materials reviewed contained conflicting figures, and the price displayed on the brand's official Longevity page changed between two live checks made in the course of preparing this article - further reason to confirm the current total directly with the brand rather than rely on any published figure, including this one
Quality management is the focus of each work
Intravenous B12 therapy is used in certain cases